FTSE All-Share
|
5 842,37
|
16,28
|
0,28 %
|
Analysen zu FTSE All-Share-Werten
| 11.09.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 10.09.24 | Glencore Buy | Deutsche Bank AG | |
| 10.09.24 | Rio Tinto Buy | Deutsche Bank AG | |
| 10.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 10.09.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 09.09.24 | GSK Buy | Deutsche Bank AG | |
| 09.09.24 | BAT Overweight | Barclays Capital | |
| 09.09.24 | AstraZeneca Sell | UBS AG | |
| 09.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 09.09.24 | Diageo Hold | Jefferies & Company Inc. | |
| 06.09.24 | Shell Overweight | JP Morgan Chase & Co. | |
| 06.09.24 | BP Underweight | JP Morgan Chase & Co. | |
| 05.09.24 | National Grid Buy | UBS AG | |
| 05.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 04.09.24 | London Stock Exchange Neutral | UBS AG | |
| 03.09.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.09.24 | Shell Overweight | JP Morgan Chase & Co. | |
| 03.09.24 | BP Underweight | JP Morgan Chase & Co. | |
| 02.09.24 | Shell Outperform | RBC Capital Markets | |
| 02.09.24 | National Grid Buy | Goldman Sachs Group Inc. | |
| 30.08.24 | Unilever Overweight | JP Morgan Chase & Co. | |
| 29.08.24 | Diageo Neutral | JP Morgan Chase & Co. | |
| 29.08.24 | BAT Neutral | JP Morgan Chase & Co. | |
| 29.08.24 | Unilever Overweight | JP Morgan Chase & Co. |